|
1
|
Callaghan MJ, Ceradini DJ and Gurtner GC:
Hyperglycemia- induced reactive oxygen species and impaired
endothelial progenitor cell function. Antioxid Redox Signal.
7:1476–1482. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li HQ, Zhao Q and Sun XN: 17β-Estradiol
enhances migratory capacity of bone marrow-derived endothelial
progenitor cells by up-regulating CXCR4 expression via estrogen
receptors pathway. Zhong Hua Shi Yan Wai Ke Za Zhi She.
26:1407–1409. 2009.
|
|
3
|
Iwakura A, Shastry S, Luedemann C, et al:
Estrogen enhances recovery after myocardial infarction by
augmenting incorporation of bone marrow-derived endothelial
progenitor cells into sites of ischemic-inducible
neovascularization via endothelial nitric oxide synthase-mediated
activation of matrix metalloproteinase-9. Circulation.
113:1605–1614. 2006.
|
|
4
|
Krenning G, van Luyn MJ and Harmsen MC:
Endothelial progenitor cell-based neovascularization: implications
for therapy. Trends Mol Med. 15:180–189. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Friedrich EB, Walenta K, Scharlau J,
Nickenig G and Werner N:
CD34−/CD133+/VEGFR-2+ endothelial
progenitor cell subpopulation with potent vasoregenerative
capacities. Circ Res. 98:e20–e25. 2006.PubMed/NCBI
|
|
6
|
Kwon SM, Eguchi M, Wada M, et al: Specific
Jagged-1 signal from bone marrow microenvironment is required for
endothelial progenitor cell development for neovascularization.
Circulation. 118:157–165. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nevskaya T, Bykovskaia S, Lyssuk E, et al:
Circulating endothelial progenitor cells in systemic sclerosis:
relation to impaired angiogenesis and cardiovascular
manifestations. Clin Exp Rheumatol. 26:421–429. 2008.
|
|
8
|
Whittaker A, Moore JS, Vasa-Nicotera M,
Stevens S and Samani NJ: Evidence for genetic regulation of
endothelial progenitor cells and their role as biological markers
of atherosclerotic susceptibility. Eur Heart J. 29:332–338. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li HQ, Zhao Q, Sun X-N, et al: Effect of
physiological estrogen on the migratory capacity of bone
marrow-derived endothelial progenitor cells. Mol Cardiol Chin.
45:79–83. 2009.
|
|
10
|
Sims NA, Dupont S, Krust A, et al:
Deletion of estrogen receptors reveals a regulatory role for
estrogen receptors-beta in bone remodeling in females but not in
males. Bone. 30:18–25. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schwartz B, Smirnoff P, Shany S, et al:
Estrogen controls expression and bioresponse of
1,25-dihydroxyvitamin D receptors in the rat colon. J Mol Cell
Biochem. 203:87–93. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Walter DH, Haendeler J, Reinhold J, et al:
Impaired CXCR4 signaling contributes to the reduced
neovascularization capacity of endothelial progenitor cells from
patients with coronary artery disease. Cirs Res. 97:1142–1151.
2005. View Article : Google Scholar
|
|
13
|
Posern G, Sotiropoulos A and Treisman R:
Mutant actins demonstrate a role for unpolymerized actin in control
of transcription by serum response factor. Mol Biol Cell.
13:4167–4178. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Amano M, Chihara K, Kimura K, et al:
Formation of actin stress fibers and focal adhesions enhanced by
Rho-kinase. Science. 275:1308–1311. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu HW, Halayko AJ, Fernandes DJ, et al:
The RhoA/Rho kinase pathway regulates nuclear localization of serum
response factor. Am J Respir Cell Mol Biol. 29:39–47. 2003.
View Article : Google Scholar : PubMed/NCBI
|
